Evidence map›Paper›PMID 28649995›Full record

ArticleImmunology and cell biology2017

Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles.

Poliana Macedo Guimarães, Bruna Miglioranza Scavuzzi, Nicole Perugini Stadtlober, Lorena Flor da Rosa Franchi Santos, Marcell Alysson Batisti Lozovoy, Tatiana Mayumi Veiga Iriyoda, Neide Tomimura Costa, Edna Maria Vissoci Reiche, Michael Maes, Isaias Dichi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Immunology and cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 3 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 3 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. FasClinical immunology (Orlando, Fla.) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. IL-21, Inflammatory Cytokines and Hyperpolarized CD8Antioxidants (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Poliana Macedo GuimarãesGraduate Program in Health Sciences, University of Londrina, Londrina, Brazil.
Bruna Miglioranza ScavuzziGraduate Program in Health Sciences, University of Londrina, Londrina, Brazil.
Nicole Perugini StadtloberGraduate Program in Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Brazil.
Lorena Flor da Rosa Franchi SantosGraduate Program in Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Brazil.
Marcell Alysson Batisti LozovoyDepartment of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Brazil.
Tatiana Mayumi Veiga IriyodaDepartment of Rheumatology, University of Londrina, Londrina, Brazil.
Neide Tomimura CostaDepartment of Rheumatology, University of Londrina, Londrina, Brazil.
Edna Maria Vissoci ReicheDepartment of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Brazil.
Michael MaesIMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Victoria, Australia.
Isaias DichiDepartment of Internal Medicine, University of Londrina, Londrina, Brazil.
Andréa Name Colado SimãoDepartment of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Brazil.
Universidade Estadual de Londrina · BRDeakin University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of this study were to delineate cytokine profiles of systemic lupus erythematosus (SLE), construct prediction models for diagnosis and disease activity using those profiles, and to examine the associations between TNFB Ncol polymorphism, body mass index (BMI) and vitamin D levels with cytokine levels. Two hundred SLE patients and 196 healthy controls participated in this case-control study. Plasma cytokines levels of tumor necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-1β, IL- 4, IL-6, IL-10, IL-12 and IL-17 were measured and cytokines profiles were computed. IL-6, IL-12, IL-17, IFN-γ and IL-10 levels were significantly higher in SLE, while IL-4 was lower in SLE. The Th1/Th2 and Th1+Th17/Th2 profiles were significantly higher in SLE than in healthy controls, whereas there were no significant differences in the proinflammatory cytokine profile (TNFα+IL-6+IL-1β). In total, 90.4% of all subjects were correctly classified using Th1+Th17 profile and IL-10 (positively associated) and IL-4 (negatively associated) as predictor variables (sensitivity=66.7% and specificity=96.9%). In all, 20.9% of the variance in the SLE Disease Activity Index was predicted by the Th1+Th17/Th2 ratio, IL-10 and BMI (all positively) and proinflammatory profile (inversely associated). B1/B1 genotype is accompanied by increased IL-17 and Th17/Th2 ratio, while B1/B2 genotype is accompanied by higher IL-4 and IFNγ values. 25-OH vitamin D was inversely associated with IFN-γ levels. SLE is accompanied by Th1, Th17 and Treg profile and lowered IL-4 production. Lowered vitamin D levels and B1/B1 genotype, but not BMI, contribute to changes in cytokines profiles. Future treatments should target Th1, Th2 and Th17 profiles rather than inflammatory cytokines.

Indexed as

AdultB-LymphocytesCase-Control StudiesCell DifferentiationCytokinesFemaleGene Expression ProfilingHumansLupus Erythematosus, SystemicMaleMiddle AgedPrognosisTh17 CellsTh1 CellsTh1-Th2 BalanceTh2 CellsCytokinesVitamin D

Identifiers

PMID28649995
OpenAlexW2695493734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.